PRODUCT DEVELOPMENT
Trubion uses proprietary technology to develop novel, single-chain polypeptide protein drugs that we believe are safer and more effective than currently available therapies. Our current product development efforts are based on three technology pillars that comprise the expanded foundation for Trubion product development – SMIP™ protein therapeutics, SCORPION™ protein therapeutics, and TRU-ADhanCe™ potency enhancing technology for immunopharmaceuticals.
PRODUCT PIPELINE
Click on a product or disease for more information.
Rheumatoid Arthritis (RA)
Rheumatoid Arthritis (RA)
Systemic Lupus Erythematosus (SLE)
Chronic Lymphocytic Leukemia (CLL)
Non-Hodgkin's Lymphoma (NHL)
Autoimmune and Inflammatory Disease (AIID)
LADA, Solid Organ Transplant
RA, IBD, AMD, DME, Diabetic Nephropathy Organ Transplant, RA, IBD